| NDC Code | 40032-700-83 |
|---|
| Package Description | 2 BOTTLE in 1 CARTON (40032-700-83) > 177 mL in 1 BOTTLE |
|---|
| Product NDC | 40032-700 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate |
|---|
| Non-Proprietary Name | Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate |
|---|
| Dosage Form | SOLUTION |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20170223 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA202511 |
|---|
| Manufacturer | Novel Laboratories, Inc. |
|---|
| Substance Name | MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE |
|---|
| Strength | 1.6; 3.13; 17.5 |
|---|
| Strength Unit | g/177mL; g/177mL; g/177mL |
|---|
| Pharmacy Classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|